| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 523896 | AVI Products AVI Products India Ltd | 30-May-2026 | Avi Products India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To approve the Standalone Audited Financial results for the Quarter and year ended 31st March 2026. 2. To recommend dividend (if any) for the financial year 2025-26. 3. Any other matter with the permission of the Chair To recommend dividend (if any) for the financial year 2025-26. |
| 524031 | Patidar Buildcon Patidar Buildcon Ltd | 30-May-2026 | Patidar Buildcon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve This is to inform you that as required under Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Meeting of Board of Directors of the Company is scheduled to be held on Saturday 30th May 2026 to consider inter alia the following businesses: 1. To consider and approve audited financial results for the quarter and year ended 31st March 2026 as per the requirement of Regulation 33 of SEBI (LODR) Regulations 2015. 2. To transact any other business with the permission of the chair. Further in terms of Companys Code of Internal Procedures & Conduct for Regulating Monitoring & Reporting of trading by Insiders framed under SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company which is closed from 01st April 2026 will remain closed up to 01ST June 2026. |
| 523550 | Krypton Industri Krypton Industries Ltd | 30-May-2026 | Krypton Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Meeting of the Board of Director is scheduled to be held on 30.05.2026 to consider and approve the Audited Standalone and Consolidated Financial Results for the year ended 31st March 2026 along with the Statutory Auditor report and any other matter with the permission of the Chairperson. |
| 524396 | Biofil Chemicals Biofil Chemicals & Pharmaceuticals Ltd | 30-May-2026 | Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the fourth Quarter as well as Financial Year ended on 31st March 2026. |
| 523842 | Super Tannery Super Tannery Ltd | 30-May-2026 | Final Dividend & Audited Results |
| 524506 | Coral Labs. Coral Laboratories Ltd | 30-May-2026 | Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday May 30 2026 inter alia to consider and approve: 1. Standalone audited financial results for the quarter and financial year ended on March 31 2026; 2. Recommendation final dividend on equity shares of the Company for the year ended on March 31 2026 if any; 3. Appointment of Internal Auditor for the financial year 2026-27; 4. Appointment of Cost Auditor for the financial year 2026-27; 5. Any other business with the permission of chairman. |
| 524546 | Satiate Agri Satiate Agri Ltd | 30-May-2026 | Satiate Agri Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended on March 31 2026. |
| 524548 | Sharma E I Hosp. Sharma East India Hosp and Medical Research Ltd | 30-May-2026 | Quarterly Results & Audited Results Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. To consider and approve the Standalone Audited Financial Results along with Auditor Report for the year ended March 31, 2026, pursuant to regulation 33 of SEBI (LODR) Regulation, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. |
| 524602 | Bandaram Pharma Bandaram Pharma Packtech Ltd | 30-May-2026 | Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited Financial Statements (Standalone and Consolidated) along with Audit Report (Standalone and Consolidated) for the Quarter and Year ended 31.03.2026. |
| 524624 | Gagan Gases Gagan Gases Ltd | 30-May-2026 | Gagan Gases Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited financial results for the quarter & Financial year ended on 31.03.2026. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
